Long non‐coding RNAs differential expression in breast cancer subtypes: What do we know?. Issue 5 (22nd January 2019)

• Record Type: Journal Article
• Authors: Mathias, Carolina; Zambalde, Erika P.; Rask, Philip; Gradia, Daniela F.; de Oliveira, Jaqueline C.
• Is Part Of: Clinical genetics. Volume 95:Issue 5(2019)
• Page Start: 558
• Page End: 568
• Publication Date: 2019-01-22
• Subjects: breast cancer -- breast cancer subtypes -- ER positive -- lncRNA; Medical genetics -- Periodicals; 616.0420
• DOI: 10.1111/cge.13502
• Languages: English
• ISSNs: 0009-9163

Abstract

Abstract : Breast Cancer (BC) is the most commonly diagnosed cancer and is the leading cause of cancer deaths in women. BC is a heterogeneous disease with different clinical and genetic features. According to immunohistochemical markers, BC is subdivided into four main subtypes: luminal A, luminal B, ERBB2 positive and triple negative. Long non‐coding RNAs (lncRNAs) are transcripts with more than 200 nucleotides and deregulated lncRNAs are associated with human diseases, including BC. In order to improve BC molecular classification, non‐coding RNAs (ncRNAs), including lncRNAs, have been used. In this review, we focus on lncRNAs with differential expression in BC subtypes and how these RNAs may act to contribute to BC heterogeneity. We also emphasize the potential of these lncRNAs as biomarkers. Abstract : LncRNAs in breast cancer.